Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Astric adenocarcinoma (1)
- Bowel movement (1)
- Cancer cells (1)
- Carcinoid syndrome (1)
- Cell migration (1)
-
- Cell signalling (1)
- Cell-matrix adhesions (1)
- Curcumin (1)
- Diarrhea (1)
- Double-Blind Method (1)
- Drug development (1)
- Drug interactions (1)
- Esophageal squamous cell carcinoma (1)
- Exit interviews (1)
- Female (1)
- Focal adhesion (1)
- Humans (1)
- Lymphocyte -specific kinase LCK (1)
- MM/GBSA (1)
- Male (1)
- Malignant Carcinoid Syndrome (1)
- Mechanical stability (1)
- Middle Aged (1)
- Molecular conformation (1)
- Patient interviews (1)
- Phenylalanine (1)
- Pyrimidines (1)
- Structure-based drug design (1)
- Substrate sensing (1)
- Talin rod controls (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Understanding The Patient Experience With Carcinoid Syndrome: Exit Interviews From A Randomized, Placebo-Controlled Study Of Telotristat Ethyl, Lowell B. Anthony, Claire Ervin, Pablo Lapuerta, Matthew H. Kulke, Pamela Kunz, Emily Bergsland, Dieter Hörsch, David C. Metz, Janice Pasieka, Nick Pavlakis, Marianne Pavel, Martyn Caplin, Kjell Öberg, John Ramage, Emily Evans, Qi Melissa Yang, Shanna Jackson, Karie Arnold, Linda Law, Dana B. Dibenedetti
Understanding The Patient Experience With Carcinoid Syndrome: Exit Interviews From A Randomized, Placebo-Controlled Study Of Telotristat Ethyl, Lowell B. Anthony, Claire Ervin, Pablo Lapuerta, Matthew H. Kulke, Pamela Kunz, Emily Bergsland, Dieter Hörsch, David C. Metz, Janice Pasieka, Nick Pavlakis, Marianne Pavel, Martyn Caplin, Kjell Öberg, John Ramage, Emily Evans, Qi Melissa Yang, Shanna Jackson, Karie Arnold, Linda Law, Dana B. Dibenedetti
Markey Cancer Center Faculty Publications
Purpose: Telotristat ethyl, an oral tryptophan hydroxylase inhibitor, is intended to treat carcinoid syndrome by reducing serotonin production. Telotristat ethyl was evaluated in TELESTAR, a Phase III study for patients who had carcinoid syndrome with at least 4 bowel movements (BMs) per day and who were receiving somatostatin analogue therapy. This interview substudy was conducted to provide insight into the patient experience in TELESTAR and to help understand whether reductions in BM frequency (the primary end point) and other symptoms were clinically meaningful.
Methods: Participating sites were asked to invite (before randomization) all eligible patients to telephone interviews scheduled at …
Mechanical Stability Of Talin Rod Controls Cell Migration And Substrate Sensing, Rolle Rahikainen, Magdaléna Von Essen, Markus Schaefer, Lei Qi, Latifeh Azizi, Conor Kelly, Teemu O. Ihalainen, Bernhard Wehrle-Haller, Martin Bastmeyer, Cai Huang, Vesa P. Hytönen
Mechanical Stability Of Talin Rod Controls Cell Migration And Substrate Sensing, Rolle Rahikainen, Magdaléna Von Essen, Markus Schaefer, Lei Qi, Latifeh Azizi, Conor Kelly, Teemu O. Ihalainen, Bernhard Wehrle-Haller, Martin Bastmeyer, Cai Huang, Vesa P. Hytönen
Markey Cancer Center Faculty Publications
Cells adhere to the surrounding tissue and probe its mechanical properties by forming cell-matrix adhesions. Talin is a critical adhesion protein and participates in the transmission of mechanical signals between extracellular matrix and cell cytoskeleton. Force induced unfolding of talin rod subdomains has been proposed to act as a cellular mechanosensor, but so far evidence linking their mechanical stability and cellular response has been lacking. Here, by utilizing computationally designed mutations, we demonstrate that stepwise destabilization of the talin rod R3 subdomain decreases cellular traction force generation, which affects talin and vinculin dynamics in cell-matrix adhesions and results in the …
Towards A Better Understanding Of On And Off Target Effects Of The Lymphocyte-Specific Kinase Lck For The Development Of Novel And Safer Pharmaceuticals, Xiaofei Zhang, Amir Kucharski, Wibe A. De Jong, Sally R. Ellingson
Towards A Better Understanding Of On And Off Target Effects Of The Lymphocyte-Specific Kinase Lck For The Development Of Novel And Safer Pharmaceuticals, Xiaofei Zhang, Amir Kucharski, Wibe A. De Jong, Sally R. Ellingson
Markey Cancer Center Faculty Publications
In this work we have developed a multi-tiered computational platform to study protein-drug interactions. At the beginning of the workflow more efficient and less accurate methods are used to enable large libraries of proteins in many conformations and massive chemical libraries to be screened. At each subsequent step in the workflow a subset of input data is investigated with increased accuracy and more computationally expensive methods. We demonstrate the developed workflow with the investigation of the lymphocyte-specific kinase LCK, which is implicated as a drug target in many cancers and also known to have toxic effects when unintentionally targeted. Several …
Potent Anti-Cancer Effects Of Less Polar Curcumin Analogues On Gastric Adenocarcinoma And Esophageal Squamous Cell Carcinoma Cells, Fatemeh Alibeiki, Naser Jafari, Maryam Karimi, Hadi Peeri Dogaheh
Potent Anti-Cancer Effects Of Less Polar Curcumin Analogues On Gastric Adenocarcinoma And Esophageal Squamous Cell Carcinoma Cells, Fatemeh Alibeiki, Naser Jafari, Maryam Karimi, Hadi Peeri Dogaheh
Markey Cancer Center Faculty Publications
Curcumin and its chalcone derivatives inhibit the growth of human cancer cells. It is reported that replacement of two OH groups in curcumin with less polar groups like methoxy increases its anti-proliferative activity. In this study, we explored benzylidine cyclohexanone derivatives with non-polar groups, to see if they possess increased anti-cancer activity. Novel 2,6-bis benzylidine cyclohexanone analogues of curcumin were synthesized, and their inhibitory effects on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cancer cells were studied using an MTT assay. Cell apoptosis was detected by EB/AO staining, and cell cycle was analyzed by flow cytometry. Real-time PCR …